Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -7,115 | -4,036 | -181 | N/A |
| Depreciation Amortization | N/A | 81 | 62 | 32 | N/A |
| Income taxes - deferred | N/A | -400 | 0 | 0 | N/A |
| Accounts payable and accrued liabilities | N/A | -175 | -169 | -58 | N/A |
| Other Working Capital | N/A | -119 | -161 | -36 | N/A |
| Other Operating Activity | 0 | 4,768 | 2,184 | -890 | 0 |
| Operating Cash Flow | $N/A | $-2,961 | $-2,121 | $-1,132 | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 1,152 | 1,152 | 1,152 | N/A |
| Financing Cash Flow | $N/A | $1,152 | $1,152 | $1,152 | $N/A |
| Beginning Cash Position | N/A | 3,335 | 3,335 | 3,335 | N/A |
| End Cash Position | N/A | 1,526 | 2,367 | 3,355 | N/A |
| Net Cash Flow | $N/A | $-1,809 | $-968 | $20 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -2,961 | -2,121 | -1,132 | N/A |
| Free Cash Flow | 0 | -2,961 | -2,121 | -1,132 | 0 |